Durable tumor regression in highly refractory metastatic KIT/PDGFRA wild-type GIST following treatment with nivolumab

Gastrointestinal stromal tumor (GIST) is a devastating disease, especially in the setting of metastasis. The natural progression of GIST has been significantly altered by the development of small molecule tyrosine kinase inhibitors (TKIs), including imatinib, sunitinib, and regorafenib, all of which...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncoimmunology
Hoofdauteurs: Schroeder, Brett A., Kohli, Karan, O’Malley, Ryan B., Kim, Theresa S., Jones, Robin L., Pierce, Robert H., Pollack, Seth M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Taylor & Francis 2020
Onderwerpen:
Brief Report
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6959429/
https://ncbi.nlm.nih.gov/pubmed/32002307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1710064
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items